Market Capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of Sept. 18, 2026, GlaxoSmithKline Pharmaceuticals (GLAXO) market capitalisation is ₹48090.98 Cr ($5.34B), with 16.94 Cr shares outstanding at a current price of ₹2838.80 on NSE, ranking 209 out of 5367 companies by market cap in our screener. GlaxoSmithKline Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. Explore GlaxoSmithKline Pharmaceutical intrinsic worth to estimate fundamental worth using multiple valuation models.
Market Cap History of GlaxoSmithKline Pharmaceuticals (Last 10 Years)
GLAXO market capitalisation from year-end NSE closing prices over the last 10 years. View GLAXO 52-week performance for the annual high/low range and current price position.
End of Year Market Cap History — GlaxoSmithKline Pharmaceuticals
GLAXO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see GlaxoSmithKline Pharmaceutical stock price NSE.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹48090.98 Cr
$5.34B USD
|
₹2838.80 | NSE | +14.76% |
| 2025 |
₹41904.27 Cr
$4.66B USD
|
₹2473.60 | NSE | +9.85% |
| 2024 |
₹38147.69 Cr
$4.24B USD
|
₹2251.85 | NSE | +18.63% |
| 2023 |
₹32155.80 Cr
$3.57B USD
|
₹1898.15 | NSE | +43.94% |
| 2022 |
₹22340.42 Cr
$2.48B USD
|
₹1318.75 | NSE | -24.93% |
| 2021 |
₹29758.71 Cr
$3.31B USD
|
₹1756.65 | NSE | +8.17% |
| 2020 |
₹27510.69 Cr
$3.06B USD
|
₹1623.95 | NSE | +0.85% |
| 2019 |
₹27279.45 Cr
$3.03B USD
|
₹1610.30 | NSE | +6.27% |
| 2018 |
₹25670.94 Cr
$2.85B USD
|
₹1515.35 | NSE | +21.75% |
| 2017 |
₹21085.12 Cr
$2.34B USD
|
₹1244.65 | NSE | -8.81% |
| 2016 |
₹23122.23 Cr
$2.57B USD
|
₹1364.90 | NSE | -17.63% |
| 2015 |
₹28071.09 Cr
$3.12B USD
|
₹1657.03 | NSE | +3.61% |
| 2014 |
₹27091.92 Cr
$3.01B USD
|
₹1599.23 | NSE | +6.68% |
| 2013 |
₹25396.50 Cr
$2.82B USD
|
₹1499.15 | NSE | +38.29% |
| 2012 |
₹18364.12 Cr
$2.04B USD
|
₹1084.03 | NSE | +11.46% |
| 2011 |
₹16476.09 Cr
$1.83B USD
|
₹972.58 | NSE | -16.78% |
| 2010 |
₹19799.33 Cr
$2.20B USD
|
₹1168.75 | NSE | +45.01% |
| 2009 |
₹13653.79 Cr
$1.52B USD
|
₹805.98 | NSE | +40.09% |
| 2008 |
₹9746.44 Cr
$1.08B USD
|
₹575.33 | NSE | +12.02% |
| 2007 |
₹8700.69 Cr
$966.74M USD
|
₹513.60 | NSE | -11.67% |
| 2006 |
₹9850.62 Cr
$1.09B USD
|
₹581.48 | NSE | +3.67% |
| 2005 |
₹9501.64 Cr
$1.06B USD
|
₹560.88 | NSE | +45.67% |
| 2004 |
₹6522.64 Cr
$724.74M USD
|
₹385.03 | NSE | +34.30% |
| 2003 |
₹4856.87 Cr
$539.65M USD
|
₹286.70 | NSE | - |